BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Lone Star Bio

  SpinalCyte, LLC Announces 25th Patent

  The company has received confirmation of the issuance of European Patent No. 2776556, “Fibroblasts For Treatment Of Degenerative Disc Disease.”

  December 27, 2017

   · 

  1 min read
• 

  BioMidwest

  PharMEDium Issues Voluntary Nationwide Recall of Certain Lots of Compounded Sterile Products Due to Lack of Sterility Assurance

  To date, PharMEDium has not received any reports of complaints related to the products but is issuing this recall out of an abundance of caution following a commitment made during a recent inspection of the company’s facility.

  December 27, 2017

   · 

  14 min read
• Drug Development

  Innovation Pharmaceuticals Obtains Direct Evidence of Molecular Pathways Modulation in Tumors From First Patients in Kevetrin PhIIa Ovarian Cancer Trial

  The findings confirm in patient tumors Kevetrin-induced anti-cancer effects similar to those demonstrated (pdf) preclinically in ovarian cancer cell-lines.

  December 27, 2017

   · 

  9 min read
• Policy

  Aeterna Zentaris Provides Update on Litigation Against David Dodd and Philip Theodore

  The Company and its Chair consider the counterclaim against them to be entirely without merit, and intend to vigorously defend against the counterclaim.

  December 27, 2017

   · 

  3 min read
• Biotech Bay

  Kalytera Announces Approval of Shares for Services and Settlement of Debt Transaction With The Salzman Group of Israel

  Under the deal, the TSXV has also approved, and the Company has completed, a settlement of certain debts previously owing through the issuance of Common Shares to The Salzman Group.

  December 27, 2017

   · 

  4 min read
• Pharm Country

  Helius Medical Technologies Announces Closing of First Tranche of Private Placement

  The net proceeds of the Private Placement will be used by the Company to finance the Company’s near-term operations and more.

  December 27, 2017

   · 

  8 min read
• Deals

  Summit Obtains Innovative Antibiotic Discovery and Development Platform Through Acquisition of Discuva Ltd.

  Under the deal, Summit acquired 100% of the issued share capital of Discuva.

  December 27, 2017

   · 

  9 min read
• Business

  Nanobiotix: 2017 Review and 2018 Expected Milestones

  Here’s an overview of the company’s anticipated 2018 milestones.

  December 27, 2017

   · 

  10 min read
• Biotech Bay

  Amarantus Subsidiary MANF Therapeutics Announces Retinal Patent Issuances in Europe Covering MANF & CDNF and Positive Data for MANF in Glaucoma

  The patents extend exclusivity for the use of MANF and CDNF in the treatment of retinal disorders in Europe into 2031.

  December 27, 2017

   · 

  6 min read
• Business

  Arrowhead Pharmaceuticals Appoints William Waddill to Board of Directors

  Arrowhead announced that the board of directors elected veteran biotechnology executive William Waddill as an independent director of the company, with a term beginning effective January 1, 2018.

  December 27, 2017

   · 

  3 min read